Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Data, Statistics and Legislation
  3. Prescription Drug Price Transparency
Topic Menu

Prescription Drug Price Transparency

  • Rx Transparency Home
  • Announcements
  • Data and Dashboards
  • Publications
  • For Reporting Entities

Related Sites

  • Health Economics Program
  • 340B Reporting
  • Accessible Prescription Drug Labels

Prescription Drug Price Transparency

  • Rx Transparency Home
  • Announcements
  • Data and Dashboards
  • Publications
  • For Reporting Entities

Related Sites

  • Health Economics Program
  • 340B Reporting
  • Accessible Prescription Drug Labels
Contact Info
Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Contact Info

Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Minnesota Rx Transparency logo

Prescription Drug Price Transparency

To increase transparency into the pricing of prescription drugs, the Minnesota Legislature passed and further amended the Minnesota Prescription Drug Price Transparency Act (the Act) requiring MDH to develop a system for collecting and reporting data from drug manufacturers, wholesalers, pharmacy benefit managers, and pharmacies on prescription drug prices (Minnesota Statutes 62J.84).

MDH will publicly post reported data on this website and produce an annual report to the legislature. In addition to synthesizing findings from data reporting, the goals of these efforts are to demonstrate how the initiative meets three goals of the law:

  • Promote transparency in pharmaceutical pricing in Minnesota.
  • Enhance the understanding of pharmaceutical spending trends.
  • Assist the state and other payers in the management of pharmaceutical costs.

Please refer to this page to monitor progress, access resources, ask questions and sign up for our email updates for news and notifications.

NEW: The March 2025 List of Drugs of Substantial Public Interest was posted by MDH on March 12—see the March 2025 List of Drugs (Excel) and March 2025 Summary & Methodology (PDF).  Reporting entities will have approximately 90 days to report. For more information, visit the Drugs of Substantial Public Interest webpage.

  • Announcements

  • Information related to the Prescription Drug Price Transparency Act.
  • Data Dashboards

  • Reported data and charts on prescription drug prices.
  • Reports/Publications

  • Reports to the legislature.
  • Meetings

  • Materials and notes from public meetings.
  • Reporting Portal

  • System for reporting entities to register & submit data.
  • Public Input

  • Provide input on drugs with substantial public interest transparency reporting.
  • Public Interest Drugs Lists

  • MDH lists of drugs of substantial public interest. 
  • Frequently Asked Questions

  • Questions and answers about Minnesota’s Prescription Drug Price Transparency Act.
  • Updated Reporting Guidance

  • Updated Reporting Guidance for Prescription Drug Price Transparency.
  • Additional Resources

  • Related resources from other agencies.
 
Tags
  • rx transparency
Last Updated: 03/11/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube